Multicomponent synthesis of dihydrobenzoxazepinones, bearing four diversity points, as potential α-helix mimics

Molecular Diversity

Volumn 14, Issue 3, 2010, Pages 425-442

  Banfi, Luca ^a   Basso, Andrea ^a   Cerulli, Valentina ^a   Guanti, Giuseppe ^a   Lecinska, Paulina ^a   Monfardini, Ilaria ^a   Riva, Renata ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Alpha helix mimics; Mitsunobu reaction; Multicomponent reactions; Ugi reaction

Indexed keywords

2 ( YDROXY) 3 (PENT 1 YL)BENZOIC ACID; 2 (BENZYLOXY) 3 (CYCLOPENTYLETHYNYL)BENZALDEHYDE; 2 (BENZYLOXY) 3 (CYCLOPENTYLETHYNYL)BENZOIC ACID; 2 (BENZYLOXY) 3 (PENT 1 YNYL)BENZALDEHYDE; 2 (BENZYLOXY) 3 (PENT 1 YNYL)BENZOIC ACID; 2 (HYDROXY) 3 (PENT 1 YL)BENZOIC ACID; 3 (CYCLOPENTYLETHYNYL)BENZALDEHYDE; 3 (PENT 1 YNYL)BENZALDEHYDE; 3 BROMO 2 BENZYLOXYBENZALDEHYDE; 3 BROMOSALICYLALDEHYDE; 3,4 DIHYDRO 4 [1 [(BUTYLAMINO)CARBONYL] 1 [[3 (PENT 1 1 YL)PHENYL]METHYL] 2 ISOBUTYLBENZO[F][1,4]OXAZEPIN 5(2H)ONE; 3,4 DIHYDRO 4 [1 [(BUTYLAMINO)CARBONYL] 1 PHENYLMETHYL] 2 ISOBUTYLBENZO[F][1,4]OXAZEPIN 5(2H)ONE; BENZOXAZINE DERIVATIVE; N METHOXY N METHYL 2 [(TERT BUTOXYCARBONYL)AMINO]ACETAMIDE; PROTEIN BCL XL; TERT BUTYL 2 BENZYLOXY 3 PHENYLPROPYLCARBAMATE; TERT BUTYL 2 BENZYLOXY 4 METHYLPENTYLCARBAMATE; TERT BUTYL 2 HYDROXY 3 PHENYLPROPYLCARBAMATE; TERT BUTYL 2 HYDROXY 4 METHYLPENTYLCARBAMATE; UNCLASSIFIED DRUG;

ALPHA HELIX; ARTICLE; CHEMICAL BINDING; CHEMICAL INTERACTION; HYDROPHOBICITY; LIPOPHILICITY; MITSUNOBU REACTION; PRIORITY JOURNAL; SYNTHESIS;

ALCOHOLS; CHEMISTRY, ORGANIC; HETEROCYCLIC COMPOUNDS, 3-RING; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; PROTEIN STRUCTURE, SECONDARY; SALICYLIC ACID;

EID: 78650177519     PISSN: 13811991     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11030-009-9210-4     Document Type: Article

References (51)

1. H Yin AD Hamilton 2005 Strategies for targeting protein-protein interactions with synthetic agents Angew Chem Int Ed Engl 44 4130 4163 1:CAS:528:DC%2BD2MXmsVartL0%3D 10.1002/anie.200461786 15954154 10.1002/anie.200461786 (Pubitemid 40982718)
2. DL Boger J Desharnais K Capps 2003 Solution-phase combinatorial libraries: modulating cellular signaling by targeting protein-protein or protein-DNA interactions Angew Chem Int Ed Engl 42 4138 4176 1:CAS:528:DC%2BD3sXnvVals7k%3D 10.1002/anie.200300574 14502729 10.1002/anie.200300574 (Pubitemid 37168929)
3. L Pagliaro J Felding K Audouze SJ Nielsen RB Terry C Krog-Jensen S Butcher 2004 Emerging classes of protein-protein interaction inhibitors and new tools for their development Curr Opin Chem Biol 8 442 449 1:CAS:528: DC%2BD2cXmt1OmsLc%3D 10.1016/j.cbpa.2004.06.006 15288255 10.1016/j.cbpa.2004.06. 006 (Pubitemid 38993738)
4. S Fletcher AD Hamilton 2005 Protein surface recognition and proteomimetics: mimics of protein surface structure and function Curr Opin Chem Biol 9 632 638 1:CAS:528:DC%2BD2MXht1aqu7fM 10.1016/j.cbpa.2005.10.006 16242379 10.1016/j.cbpa.2005.10.006 (Pubitemid 41612192)
5. A Khorchid P Beauparlant 2004 Bcl-2-targeted cancer therapeutics Expert Opin Ther Patents 14 805 818 1:CAS:528:DC%2BD2cXktlyqs7c%3D 10.1517/13543776.14. 6.805 10.1517/13543776.14.6.805 (Pubitemid 38868064)
6. NE Shepherd HN Hoang VS Desai E Letouze PR Young DP Fairlie 2006 Modular alpha-helical mimetics with antiviral activity against respiratory syncitial virus J Am Chem Soc 128 13284 13289 1:CAS:528:DC%2BD28XpsF2itLg%3D 10.1021/ja064058a 17017810 10.1021/ja064058a (Pubitemid 44527700)
7. JD Sadowsky WD Fairlie EB Hadley HS Lee N Umezawa Z Nikolovska-Coleska SM Wang DCS Huang Y Tomita SH Gellman 2007 (alpha/beta+alpha)-Peptide antagonists of BH3 Domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions J Am Chem Soc 129 139 154 1:CAS:528:DC%2BD28XhtlWlsL3M 10.1021/ja0662523 17199293 10.1021/ja0662523 (Pubitemid 46068270)
8. R Ponassi B Biasotti V Tomati S Bruno A Poggi D Malacarne G Cimoli A Salis S Pozzi M Miglino, et al. 2008 A novel Bim-BH3-derived Bcl-X-L inhibitor biochemical characterization, in vitro, in vivo and ex-vivo anti-leukemic activity Cell Cycle 7 3211 3224 1:CAS:528:DC%2BD1cXhsV2mu7fO 18843207
9. JM Davis LK Tsou AD Hamilton 2007 Synthetic non-peptide mimetics of alpha-helices Chem Soc Rev 36 326 334 1:CAS:528:DC%2BD2sXhtVKlurg%3D 10.1039/b608043j 17264933 10.1039/b608043j
10. H Yin GI Lee KA Sedey JM Rodriguez HG Wang SM Sebti AD Hamilton 2005 Terephthalamide derivatives as mimetics of helical peptides: disruption of the Bcl-x(L)/Bak interaction J Am Chem Soc 127 5463 5468 1:CAS:528: DC%2BD2MXis1Ojsrg%3D 10.1021/ja0446404 15826183 10.1021/ja0446404 (Pubitemid 40569857)
11. H Yin GI Lee HS Park GA Payne JM Rodriguez SM Sebti AD Hamilton 2005 Terphenyl-based helical mimetics that disrupt the p53/HDM2 interaction Angew Chem Int Ed Engl 44 2704 2707 1:CAS:528:DC%2BD2MXkt1Chtrs%3D 10.1002/anie.200462316 15765497 10.1002/anie.200462316 (Pubitemid 40689569)
12. JM Davis A Truong AD Hamilton 2005 Synthesis of a 2,3′;6′, 3″-terpyridine scaffold as an alpha-helix mimetic Org Lett 7 5405 5408 1:CAS:528:DC%2BD2MXhtFKlt7%2FL 10.1021/ol0521228 16288517 10.1021/ol0521228 (Pubitemid 41775143)
13. H Yin GI Lee KA Sedey O Kutzki HS Park BP Omer JT Ernst HG Wang SM Sebti AD Hamilton 2005 Terphenyl-based bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-X-L J Am Chem Soc 127 10191 10196 1:CAS:528:DC%2BD2MXlvVajtb4%3D 10.1021/ja050122x 16028929 10.1021/ja050122x (Pubitemid 41045484)
14. JM Ahn SY Han 2007 Facile synthesis of benzamides to mimic an alpha-helix Tetrahedron Lett 48 3543 3547 1:CAS:528:DC%2BD2sXksVehs7s%3D 10.1016/j.tetlet.2007.03.108 10.1016/j.tetlet.2007.03.108 (Pubitemid 46590196)
15. H Oguri S Tanabe A Oomura M Umetsu M Hirama 2006 Synthesis and evaluation of alpha-helix mimetics based on a trans-fused polycyclic ether: sequence-selective binding to aspartate pairs in alpha-helical peptides Tetrahedron Lett 47 5801 5805 1:CAS:528:DC%2BD28XmvFers7s%3D 10.1016/j.tetlet.2006.05.170 10.1016/j.tetlet.2006.05.170
16. SM Biros L Moisan E Mann A Carella D Zhai JC Reed J Rebek 2007 Heterocyclic alpha-helix mimetics for targeting protein-protein interactions Bioorg Med Chem Lett 17 4641 4645 1:CAS:528:DC%2BD2sXotFSitbk%3D 10.1016/j.bmcl.2007.05.075 17555961 10.1016/j.bmcl.2007.05.075 (Pubitemid 47064505)
17. A Volonterio L Moisan J Rebek 2007 Synthesis of pyridazine-based scaffolds as alpha-helix mimetics Org Lett 9 3733 3736 1:CAS:528: DC%2BD2sXpt1Wit70%3D 10.1021/ol701487g 17711290 10.1021/ol701487g
18. M Prakesch AY Denisov M Naim K Gehring P Arya 2008 The discovery of small molecule chemical probes of Bcl-X-L and Mcl-1 Bioorg Med Chem 16 7443 7449 1:CAS:528:DC%2BD1cXps12jur0%3D 10.1016/j.bmc.2008.06.023 18603434 10.1016/j.bmc.2008.06.023
19. BL Grasberger TB Lu C Schubert DJ Parks TE Carver HK Koblish MD Cummings LV LaFrance KL Milkiewicz RR Calvo, et al. 2005 Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells J Med Chem 48 909 912 1:CAS:528:DC%2BD2MXosFWmtg%3D%3D 10.1021/jm049137g 15715460 10.1021/jm049137g (Pubitemid 40270436)
20. MD Cummings C Schubert DJ Parks RR Calvo LV LaFrance J Lattanze KL Milkiewicz TB Lu 2006 Substituted 1,4-benzodiazepine-2,5-diones as alpha-helix mimetic antagonists of the HDM2-p53 protein-protein interaction Chem Biol Drug Design 67 201 205 1:CAS:528:DC%2BD28Xkslejurc%3D 10.1111/j.1747-0285.2006.00365. x 10.1111/j.1747-0285.2006.00365.x
21. P Raboisson JJ Marugan C Schubert HK Koblish TB Lu SY Zhao MR Player AC Maroney RL Reed ND Huebert, et al. 2005 Structure-based design, synthesis, and biological evaluation of novel 1,4-diazepines as HDM2 antagonists Bioorg Med Chem Lett 15 1857 1861 1:CAS:528:DC%2BD2MXisVCntLc%3D 10.1016/j.bmcl.2005.02.018 15780621 10.1016/j.bmcl.2005.02.018 (Pubitemid 40380747)
22. W Antuch S Menon QZ Chen YC Lu S Sakamuri B Beck V Schauer-Vukasinovic S Agarwal S Hess A Domling 2006 Design and modular parallel synthesis of a MCR derived alpha-helix mimetic protein-protein interaction inhibitor scaffold Bioorg Med Chem Lett 16 1740 1743 1:CAS:528:DC%2BD28Xht1ymsb0%3D 10.1016/j.bmcl.2005.11.102 16427279 10.1016/j.bmcl.2005.11.102 (Pubitemid 43197557)
23. A Domling W Antuch B Beck V Schauer-Vukasinovic 2008 Isosteric exchange of the acylsulfonamide moiety in Abbott's Bcl-X-L protein interaction antagonist Bioorg Med Chem Lett 18 4115 4117 10.1016/j.bmcl.2008.05.096 18583128 10.1016/j.bmcl.2008.05.096
24. Zhu J, Bienaymé H (2005) Multicomponent reactions. Wiley, Weinheim
25. C Hulme J Dietrich 2009 Emerging molecular diversity from the intra-molecular Ugi reaction: iterative efficiency in medicinal chemistry Mol Divers 13 195 207 1:CAS:528:DC%2BD1MXltV2hsbc%3D 10.1007/s11030-009-9111-6 19205916 10.1007/s11030-009-9111-6
26. I Akritopolou-Zanze 2008 Isocyanide-based multicomponent reactions in drug discovery Curr Opin Chem Biol 12 324 331 10.1016/j.cbpa.2008.02.004 10.1016/j.cbpa.2008.02.004
27. A Domling 2006 Recent developments in isocyanide based multicomponent reactions in applied chemistry Chem Rev 106 17 89 10.1021/cr0505728 16402771 10.1021/cr0505728 (Pubitemid 43159621)
28. C Hulme T Nixey 2003 Rapid assembly of molecular diversity via exploitation of isocyanide-based multi-component reactions Curr Opin Drug Discov Develop 6 921 929 1:CAS:528:DC%2BD2cXhs1WmsQ%3D%3D
29. Zhu JP (2003) Recent developments in the isonitrile-based multicomponent synthesis of heterocycles. Eur J Org Chem 1133-1144. doi: 10.1002/ejoc.200390167
30. L Banfi A Basso G Guanti P Lecinska R Riva 2008 Multicomponent synthesis of benzoxazinones via tandem Ugi/Mitsunobu reactions: an unexpected cine-substitution Mol Divers 12 187 190 1:CAS:528:DC%2BD1cXhtlWhtb7I 10.1007/s11030-008-9087-7 18763045 10.1007/s11030-008-9087-7
31. L Banfi A Basso G Guanti P Lecinska R Riva V Rocca 2007 Multicomponent synthesis of novel 2- and 3-substituted dihydrobenzo[1,4]oxazepinones and tetrahydrobenzo[1,4]diazepin-5-ones and their conformational analysis Heterocycles 73 699 728 1:CAS:528:DC%2BD1cXhs1SmtA%3D%3D 10.3987/COM-07-S(U)51
32. L Banfi A Basso G Guanti N Kielland C Repetto R Riva 2007 Ugi multicomponent reaction followed by an intramolecular nucleophilic substitution: convergent multicomponent synthesis of 1-sulfonyl 1,4-diazepan-5-ones and of their benzo-fused derivatives J Org Chem 72 2151 2160 1:CAS:528: DC%2BD2sXhvFKku7k%3D 10.1021/jo062626z 17309311 10.1021/jo062626z (Pubitemid 46418421)
33. L Banfi A Basso G Guanti P Lecinska R Riva 2006 Multicomponent synthesis of dihydrobenzoxazepinones by coupling Ugi and Mitsunobu reactions Org Biomol Chem 4 4236 4240 1:CAS:528:DC%2BD28XhtFKitrzF 10.1039/b613056a 17312981 10.1039/b613056a (Pubitemid 44665197)
34. Developed and sold by CambridgeSoft, 100 CambridgePark Drive, Cambridge, MA 02140 USA. URL: http://www.cambridgesoft.com/
35. O Kutzki HS Park JT Ernst BP Orner H Yin AD Hamilton 2002 Development of a potent Bcl-x(L) antagonist based on alpha-helix mimicry J Am Chem Soc 124 11838 11839 1:CAS:528:DC%2BD38XmvVyktbY%3D 10.1021/ja026861k 12358513 10.1021/ja026861k
36. AA Lugovskoy AI Degterev AF Fahmy P Zhou JD Gross J Yuan G Wagner 2002 A novel approach for characterizing protein ligand complexes: molecular basis for specificity of small-molecule Bcl-2 inhibitors J Am Chem Soc 124 1234 1240 1:CAS:528:DC%2BD38XntlGjsA%3D%3D 10.1021/ja011239y 11841292 10.1021/ja011239y (Pubitemid 34169130)
37. W Feng SY Huang H Wu MJ Zhang 2007 Molecular basis of Bcl-xL's target recognition versatility revealed by the structure of Bcl-xL in complex with the BH3 domain of beclin-1 J Mol Biol 372 223 235 1:CAS:528:DC%2BD2sXovFeqsr8%3D 10.1016/j.jmb.2007.06.069 17659302 10.1016/j.jmb.2007.06.069 (Pubitemid 47223231)
38. D Buckley J Thomas 1971 Synthesis of alkylsalicylic acids as antimicrobial agents J Med Chem 14 265 1:CAS:528:DyaE3MXoslGmug%3D%3D 10.1021/jm00285a031 5552227 10.1021/jm00285a031
39. KN Tramposch KH F. M Blau 1983 Radioiodine-labeled N,N-dimethyl-N'-[2- hydroxy-3-alkyl-5-iodobenzyl]-1,3-propanediamines for brain perfusion imaging J Med Chem 26 121 125 1:CAS:528:DyaL3sXkvFKntA%3D%3D 10.1021/jm00356a001 6402595 10.1021/jm00356a001 (Pubitemid 13187331)
40. KW Gano DC Myles 2000 Progress toward the synthesis of a biomimetic membrane Tetrahedron Lett 41 4247 4250 1:CAS:528:DC%2BD3cXktlWhu74%3D 10.1016/S0040-4039(00)00597-9 10.1016/S0040-4039(00)00597-9
41. NU Hofslokken L Skattebol 1999 Convenient method for the ortho-formylation of phenols Acta Chem Scand 53 258 262 1:CAS:528: DyaK1MXit1eqs70%3D 10.3891/acta.chem.scand.53-0258 10.3891/acta.chem.scand.53- 0258
42. E Verner BA Katz JR Spencer D Allen J Hataye W Hruzewicz HC Hui A Kolesnikov Y Li C Luong, et al. 2001 Development of serine protease inhibitors displaying a multicentered short (<2.3 angstrom) hydrogen bond binding mode: inhibitors of urokinase-type plasminogen activator and factor Xa J Med Chem 44 2753 2771 1:CAS:528:DC%2BD3MXltVSitrw%3D 10.1021/jm0100638 11495587 10.1021/jm0100638 (Pubitemid 32879717)
43. NG Kundu M Pal JS Mahanty M De 1997 Palladium-catalysed heteroannulation with acetylenic compounds: synthesis of benzofurans J Chem Soc, Perkin Trans 1 2815 2820 10.1039/a703305b 10.1039/a703305b
44. KS Feldman KJ Eastman G Lessene 2002 Diazonamide synthesis studies: use of Negishi coupling to fashion diazonamide-related biaryls with defined axial chirality Org Lett 4 3525 3528 1:CAS:528:DC%2BD38Xms1WnsLw%3D 10.1021/ol026694t 12323060 10.1021/ol026694t
45. YR Lee X Wang 2005 A short synthetic route to biologically active (±)-daurichromenic acid as highly potent anti-HIV agent Org Biomol Chem 3 3955 3957 1:CAS:528:DC%2BD2MXht1ehtb%2FJ 10.1039/b508577b 16240013 10.1039/b508577b (Pubitemid 41640808)
46. Incarvito C, Lam M, Rhatigan B, Rheingold AL, Qin CJ, Gavrilova AL, Bosnich B (2001) Bimetallic reactivity. Preparations, properties and structures of complexes formed by unsymmetrical binucleating ligands bearing 4-and 6-coordinate sites supported by alkoxide bridges. J Chem Soc, Dalton Trans 3478-3488. doi: 10.1039/b103164n (Pubitemid 35166686)
47. JL Buchanan CB Vu TJ Merry EG Corpuz SG Pradeepan UN Mani M Yang HR Plake VM Varkhedkar BA Lynch, et al. 1999 Structure-activity relationships of a novel class of Src SH2 inhibitors Bioorg Med Chem Lett 9 2359 2364 1:CAS:528:DyaK1MXlslWhurg%3D 10.1016/S0960-894X(99)00389-3 10476869 10.1016/S0960-894X(99)00389-3 (Pubitemid 29391522)
48. J Liu N Ikemoto D Petrillo JD Armstrong 2002 Improved syntheses of alpha-BOC-aminoketones from alpha-BOC-amino-Weinreb amides using a pre-deprotonation protocol Tetrahedron Lett 43 8223 8226 1:CAS:528: DC%2BD38XotVylur0%3D 10.1016/S0040-4039(02)02031-2 10.1016/S0040-4039(02)02031-2 (Pubitemid 35223342)
49. G Bartoli M Bosco A Carlone M Locatelli P Melchiorre L Sambri 2004 Asymmetric catalytic synthesis of enantiopure N-protected 1,2-amino alcohols Org Lett 6 3973 3975 1:CAS:528:DC%2BD2cXotVShs7o%3D 10.1021/ol048322l 15496077 10.1021/ol048322l (Pubitemid 39523264)
50. Kauch M, Hoppe D (2006) Synthesis of halogenated phenols by directed ortho-lithiation and ipso-iododesilylation reactions of O-aryl N-isopropylcarbamates. Synthesis 1578-1589. doi: 10.1055/s-2006-926462 (Pubitemid 43805964)
51. P Brown DT Davies PJ Ohanlon JM Wilson 1996 The chemistry of pseudomonic acid. 15. Synthesis and antibacterial activity of a series of 5-alkyl, 5-alkenyl, and 5-heterosubstituted oxazoles J Med Chem 39 446 457 1:CAS:528:DyaK28XmvVKi 10.1021/jm9503862 8558513 10.1021/jm9503862 (Pubitemid 26041457)